Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

A mobile app designed to guide adults with recurrent vertigo through repositioning maneuvers has been announced. It aims to improve self-treatment accuracy and reduce recurrence. The app is targeting both consumers and ENT clinics for home care use.

A new vertigo relief app has been announced to help adults suffering from recurrent benign paroxysmal positional vertigo (BPPV) perform repositioning maneuvers like the Epley correctly at home. The app aims to address long-standing challenges in self-treatment and could be recommended by ENT clinics and vestibular physiotherapists, marking a significant step toward digital vestibular rehabilitation.

The app is designed as a mobile platform for both iOS and Android devices. It will include screening tools, animated step-by-step guidance for maneuvers such as the Epley and Brandt-Daroff, and real-time head-angle feedback using smartphone gyroscopes. Users will be able to log dizziness episodes, triggers, and symptom severity over time, supporting better self-management.

Developers plan to launch a freemium model, offering basic maneuver guidance free of charge, with paid features like detailed tracking, history export, and reminders. Learn more about our guest app with day-of seating lookup and schedule. Additionally, ENT clinics and audiology practices can license the app for patient use, integrating it into their home care protocols. The initiative responds to increasing demand for digital therapeutics in vestibular care, driven by shifts toward telehealth accelerated during the COVID-19 pandemic.

Potential Impact on Vertigo Self-Management and Clinical Practice

This app could significantly improve the accuracy of self-administered repositioning maneuvers, reducing incorrect treatments and recurrence rates, which affect roughly half of BPPV cases. By enabling better at-home management, it may decrease reliance on specialist visits, lower healthcare costs, and improve quality of life for patients. Its adoption by clinics could streamline patient care and foster broader acceptance of digital vestibular therapies.

Nature's Fusions Vertigo Relief, Ginger Oil Nausea Relief Essential Oil Blends (15ml) – Fast-Acting Motion Sickness Relief, Morning Sickness Relief, Dizziness Relief, & Vertigo Medicine w/ Peppermint

• Fast-Acting Relief: Works in as quick as 5 minutes
• Natural & Pure: Contains 100% pure, therapeutic-grade oils
• Versatile Use: Suitable for vertigo, nausea, migraines, and motion sickness

View Latest Price

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Growing Market and Technological Readiness for Digital Vertigo Solutions

The digital therapeutics market for vestibular disorders was valued near USD 498 million in 2024, with an expected compound annual growth rate of approximately 13.5% through 2033. The COVID-19 pandemic accelerated telehealth adoption, increasing interest in remote management tools. Smartphones now contain highly accurate motion sensors capable of providing real-time feedback, making app-based interventions feasible and potentially effective. Prior to this, patients often struggled with static diagrams and lacked guided support, leading to frequent mis-treatments and recurrences.

While the app is still in development, its approach aligns with current trends toward digital health solutions for chronic conditions, especially as reimbursement models for digital therapeutics continue to mature.

“The app aims to improve self-treatment accuracy for BPPV patients and could reduce recurrence rates by providing guided, real-time feedback.”

— an anonymous researcher

Unconfirmed Details About App Deployment and Clinical Integration

It is not yet clear when the app will be publicly available or how quickly clinics will adopt it for patient home care. The effectiveness of the app in reducing recurrence rates remains to be validated through clinical trials or user testing. Additionally, the scope of its integration with existing healthcare systems and reimbursement pathways is still under discussion.

Next Steps: Pilot Testing and Market Validation Strategies

Developers plan to launch a lightweight landing page and a no-code guided Epley maneuver walkthrough to gather user interest and validate demand. They will run targeted advertising campaigns to vertigo-related search terms, measure signups, and track completion rates. Simultaneously, they will pitch ENT and audiology clinics to trial the app with patients, assessing clinician interest and potential integration into existing care protocols.

Key Questions

When will the vertigo relief app be available to the public?

It is currently in development, with no confirmed release date. Developers plan to conduct validation and pilot testing before a wider launch.

Can the app replace visits to ENT specialists?

No. The app is intended as a supplemental tool for home management and should be used in conjunction with medical advice. It includes disclaimers emphasizing the need for clinical consultation when red-flag symptoms occur.

Will clinics be able to license the app for patient use?

Yes, developers are exploring a licensing model for ENT, audiology, and vestibular physiotherapy practices to recommend the app as part of their patient care programs.

How will the app ensure correct maneuver execution?

The app will use gyroscope-based head-angle feedback and animated cues to guide users through maneuvers, aiming to improve accuracy over static diagrams.

What evidence supports the app’s effectiveness?

Effectiveness data is still being gathered. The development team plans to validate the app through user testing, clinical trials, and feedback from early adopters.

Source: IdeaNavigator AI